Prelude Corp filed a Form D with the Securities and Exchange Commission on 2025-11-06.
Prelude Corp filed a Form D notice of an exempt securities offering with the SEC on November 6, 2025. The filing reports $5M sold. Its industry group is Biotechnology. It names Olav Bergheim (Executive Officer, Director), Andrew Wade (Executive Officer), Daniel Forche (Executive Officer, Director) (SEC Form D, November 6, 2025).
Is this your company?
Sell to companies like Prelude Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-06 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Prelude Corp.
Free to see. No signup.
More on the people and the money behind Prelude Corp, from the filings we hold.
Biotechnology raises by companies based in California, filed in November 2025, largest first.
Get an email when Prelude Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Prelude Corp raises, hires or launches. No email unless you switch it on.
Watch Prelude Corp →Get the full cited report on Prelude Corp
What the filing shows about Prelude Corp
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Prelude Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Prelude Corp's address as 26051 Merit Circle, Suite 102, Laguna Hills, CA 92653.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Prelude Corp is a registered filer with the SEC (CIK 1669317) and has filed since 2025-11-06. 1 filing is on record, the latest on 2025-11-06.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Prelude Corp's Form D of 2025-11-06 names Olav Bergheim, Andrew Wade, Daniel Forche and 3 more as its officers, directors or promoters.
Its new offerings report $5M sold across 1 offering, as its own filings state.
Trailing twelve months. 764 filings in Biotechnology, totalled by week. The dot is this raise, $5M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Olav Bergheim is named as Executive Officer and Director on the Form D that Prelude Corp filed with the SEC on 6 November 2025, one of 6 people that filing names.
Andrew Wade is named as Executive Officer on the Form D that Prelude Corp filed with the SEC on 6 November 2025, one of 6 people that filing names.
Daniel Forche is named as Executive Officer and Director on the Form D that Prelude Corp filed with the SEC on 6 November 2025, one of 6 people that filing names.
Gerrit Adams is named as Director on the Form D that Prelude Corp filed with the SEC on 6 November 2025, one of 6 people that filing names.
Derek Maetzold is named as Director on the Form D that Prelude Corp filed with the SEC on 6 November 2025, one of 6 people that filing names.
Alejandro Sanchez is named as Director on the Form D that Prelude Corp filed with the SEC on 6 November 2025, one of 6 people that filing names.
6 people named on the filing — 3 holding an executive role and 3 as directors only.
Named as of the 2025-11-06 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Prelude Corp
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Prelude Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Prelude Corp covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Prelude CorpYou get an alert in MentionFox the next time this company shows up.
If you're behind Prelude Corp: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Prelude Corp. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Los Angeles
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/prelude-corp-form-d-25000001